1999
DOI: 10.1159/000016919
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Options in Patients with Barrett’s Esophagus

Abstract: The rising incidence of esophageal adenocarcinoma has focused attention on the only known risk factor: Barrett’s esophagus. Practice guidelines for the diagnosis, surveillance and management of Barrett’s esophagus were published recently. Although the ultimate goal in the management of this premalignant condition would be the permanent elimination of Barrett’s mucosa, current therapeutic options are limited or still in the investigational stages. This review summarizes current medical and surgical treatment op… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2001
2001
2008
2008

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 49 publications
0
6
0
Order By: Relevance
“…In the US and other Western countries, overall rates of esophageal cancer (EC) as well as squamous cell carcinoma (SCC) have been decreasing 1,2 probably due to the reductions in the rate of cigarette smoking, 3,4 while rates of adenocarcinoma (AC) have been on the rise, 5 probably as a consequence of increasing Barrett's esophagus. [6][7][8] In fact, AC has supplanted SCC as the predominant histological type of EC in the US and currently accounts for over half of new esophageal cancers in the US, especially among white males. 9 The southern side of the Caspian littoral historically has had high rates of esophageal cancer.…”
Section: Introductionmentioning
confidence: 99%
“…In the US and other Western countries, overall rates of esophageal cancer (EC) as well as squamous cell carcinoma (SCC) have been decreasing 1,2 probably due to the reductions in the rate of cigarette smoking, 3,4 while rates of adenocarcinoma (AC) have been on the rise, 5 probably as a consequence of increasing Barrett's esophagus. [6][7][8] In fact, AC has supplanted SCC as the predominant histological type of EC in the US and currently accounts for over half of new esophageal cancers in the US, especially among white males. 9 The southern side of the Caspian littoral historically has had high rates of esophageal cancer.…”
Section: Introductionmentioning
confidence: 99%
“…Thermal destruction is due to the rapid transfer of energy to the target tissue and is strongly related to wavelength. Argon and KTP lasers penetrate tissue to approximately 1 mm, whereas Nd: YAG will cause destruction to 3–4 mm 9,33 The KTP laser offers the advantages of more precise control of depth of injury by variation of pulse duration, however, the relatively shallow depth of injury may result in incomplete destruction of the BE. It is a non‐contact technique with the laser beam applied to the surface in a paintbrush fashion.…”
Section: Methodsmentioning
confidence: 99%
“…7,8 A variety of techniques have been used for the elimination of intestinal metaplasia including laser, photodynamic or electrocoagulation therapy, argon beam plasma coagulation and endoscopic resection. 9 Whichever modality of ablation is used, there are limitations both in terms of efficacy and unwanted effects. The indications for active management of BE and esophageal adenocarcinoma, and the role of ablative techniques in this process are obscure.…”
Section: Introductionmentioning
confidence: 99%
“…In spite of publication of the ACG guidelines in the American Journal of Gastroenterology and ample citation of the guidelines in other articles, [22][23][24][25] only 55% of all respondents in our sample were aware of the guidelines 18 months after their publication. Although ACG members were more likely to be aware than nonmembers, only 61% of the former group knew of the guidelines despite uniform distribution of the journal to all society members.…”
Section: Commentmentioning
confidence: 99%